NEW YORK, NY / ACCESSWIRE / March 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive report with no obligation on Defense Technologies International Corp. (OTCQB: DTII). Defense and security related spending in the US is expected to grow after multi-year muted defense budgets. This future growth is triggered by the new US administration’s increased focus on strengthening the US military.

The first budget of the new government is likely to call for around $54 billion increase in defense spending and a corresponding cut in lower priority programs. The U.S. spends more money on defense than any country in the world, by far, with an annual defense budget of nearly $600 billion.

Key stock influences and recent developments are discussed in more detail here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/defense-technologies-dtii/

About the Industry

Defense Technologies International Corp. (OTCQB: DTII) (the “Company”) is a developer of security technologies. It is a holding company that includes Passive Security Scan, Inc., a wholly owned subsidiary. Passive Security Scan, Inc. is the manufacturer of The Offender Alert Passive Scan™, a non- X-ray scanner for use at schools, universities, stadiums, hospitals, and other commercial buildings.

About the Offender Alert Passive Scan

The Company’s “Offender Alert Passive Scan™” is a “next generation” walk-through detector-scanning unit. This patented and trademarked passive scanning system allows for detecting and identifying concealed threats such as guns, knives, etc. Unlike other scanners the public is more familiar with, Passive Security Scan does NOT use X-rays to detect threats. Serious health concerns have been raised over the repeated exposure to X-rays from other scanning machines currently in use. The Offender Alert Passive Scan™ scanner technology is based on the “Earth Magnetic Fields” has no emission whatsoever, and is, therefore, extremely safe and harmless to the person passing through their portal.

As per management, Scanner Portal will soon be ready for installation in real world venues, with primary concentration on schools in the United States and other countries around the world, as well as other venues of public assembly.

A comprehensive review of this technology and forward outlook is available here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/defense-technologies-dtii/

DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles, and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated, directly or indirectly, for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email at: editor@tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

ReleaseID: 457778

LOS ANGELES, CA / ACCESSWIRE / March 21, 2017 / Sumitomo Electric Industries, Ltd., a leading global provider of advanced optical solutions, will showcase its next generation optical products at OFC 2017, to be held on March 21-23, in the Los Angeles Convention Center, Los Angeles, CA, USA.

Cloud-based services are driving growth of networks, and data centers are in need for capacity upgrades. With a new generation of high-capacity equipment coming to market, Sumitomo Electric will be ready to deliver high speed optical 100G optical solutions. Sumitomo Electric will showcase its family of 100G optical devices and modules, as well as next-generation 200G and 400G optical products.

QSFP28 ER4 Lite

100G is becoming mainstream in many applications and QSFP28 is the most compact transceiver leading in 100G optical modules. The QSFP28 100G-ER4 Lite transceiver SQF1000EL is designed to address mid-reach MSA Ethernet applications. 100G QSFP28 has 4 x 25 Gig channels, linking distance up to 40 km. The IEEE standard uses a power-consuming semiconductor optical amplifier (SOA) prior to the PIN photodetector to cover 40 km. The QSFP28 ER4 Lite replaces the SOA and PIN with an avalanche photo diode (APD) and external forward error correction to reduce the power consumption, while maintaining the optical link budget.

400G CFP8

Hyperscale data centers need high density to respond to the increase in server bandwidth for client applications. The 400G CFP8 transceiver is compliant with IEEE 802.3bs 400GBASE-LR8/FR8 specifications for links up to 10 km. The SFF4801 series leverages Sumitomo Electric electro-absorption modulated lasers (EMLs), as well as its PIN photodiodes. The 400GE can support 12.8Tb/s on a switch faceplate and is ideal for metro applications between data centers and clients.

QUOTE from Light Counting

“Large data centers are looking for longer-reach 100G switch-to-switch connections in the very popular QSFP28 form factor. Sumitomo Electric’s ER4 Lite will offer this desired functionality, while consuming modest power,” remarked Dale Murray, Principal Analyst, LightCounting Market Research. “In addition, 400G CFP8 transceivers will help launch the new generation of speed, while providing necessary reaches.”

Sumitomo Electric continues to lead in innovation and technology that help customers with time to market for next generation complex systems. Visit Sumitomo Electric, Booth 2703, to learn more.

About Sumitomo Electric Industries, Ltd.

Sumitomo Electric Industries, Ltd. was established in 1897. With the history in electric wire and cable manufacturing, Sumitomo Electric has invested heavily over the years in research and development to expand and establish new businesses. These efforts have allowed us to create new products and new technologies, as well as diversify our business fields. Currently, we operate our businesses on a global basis in five segments: Automotive; Infocommunications; Electronics; Environment & Energy; and Industrial Materials. We will continue to contribute to society through environmental friendly and fair business activities globally.

For more information, visit http://global-sei.com.

Press Contact:

Effie Favreau
Global Marketing
efavreau@sei-device.com

SOURCE: Sumitomo Electric Industries, Ltd.

ReleaseID: 457772

NEW YORK, NY / ACCESSWIRE / March 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive report with no obligation on TSS, Inc. (OTCQB: TSSI). In their most recent earnings announcement for Third quarter 2016, TSSI reported revenue of $5.4 million, compared with $6.3 million in the third quarter of 2015, along with Gross margin of 27% (Q3-2016), as against 32% during Q3-2015.

Notwithstanding this muted performance, the company is bullish about the changes they made in business during third quarter (2016) and additional streams of business that the company has recently won. TSSI is optimistic about 2017 as they further develop its systems integration and modular facilities businesses.

We discuss these changes and TSS’s financials in detail here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/tssi/

About the Company

TSS is a provider of mission-critical planning, design, system integration, deployment, maintenance, and evolution of data centers facilities and information infrastructure. TSS specializes in customizable end-to-end solutions powered by industry experts and innovative services that include technology consulting, engineering, design, construction, operations, facilities management, technology system installation and integration, as well as maintenance for traditional and modular data centers.

Major Client Set

Over the last 3 decades, TSS has worked with organizations large and small in almost every public and private sector industry. TSS provides full-lifecycle solutions for each client’s unique mission-critical needs and enterprise objectives. As a critical facility focused solution provider, TSS services a majority of private and public sector markets. Its solutions scale from small server and telecom rooms, to large purpose built facilities, to now even modular data centers.

A full comprehensive report on TSS is available here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/tssi/

DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles, and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated, directly or indirectly, for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email between 09:30 EST to 16:00 EST from Monday through Friday at: editor@tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

ReleaseID: 457777

“I would submit to you that within the intermediate term time frame, that is, the 3- to 5-year timeframe, we have two expectations. One alternative is that the price of uranium goes up to the cost of production or the other is that the lights go out. And my suspicion is that it will be the former rather than the latter.” – “Sprott’s Thoughts” Rick Rule, March 2017

VANCOUVER, BC / ACCESSWIRE / March 21, 2017 / Christmas 2016 was not very merry for Uranium investors. Even the bears were likely surprised when the price cracked below $22, then $20, $19, $18…

Contrarians did well as some uranium juniors followed the subsequent post Xmas price correction to the current $24 level with gains of in some cases multiple 100’s of percent.

In the new Trump regime uranium prices started rising almost immediately after the polls closed on November 8th, 2016. Since then, the bellwether uranium ETF, URA is also up impressively, as is bellwether U308 stock and Cameco. The former rose from $12 to $17 and Cameco is up to $11 from $8.

Cameco states: “Ux Consulting Company, LLC (UxC) reports that over the last four years only 245 million pounds have been locked-up in the long-term market, while over 635 million pounds have been consumed in reactors. As annual supply adjusts and utilities’ uncovered requirements grow, the pounds available in the spot market won’t be enough to satisfy the demand.”

This supply/demand discussion is well illustrated in Argentina. Nikolaos Cacos President and CEO of Argentine-focused Blue Sky Uranium Corp (TSX-V: BSK, FSE: MAL2; OTC: BKUCF) states: “BSK is targeting the Argentina market where growing nuclear power demand has no local uranium supply; all uranium is imported.”

The Argentina Atomic Energy National Commission’s (CNEA) mandate– To ensure the supply of domestic uranium for nuclear power plants in operation, under construction and planned” is what fuels BSK aggressive development activities.”

This growth outlook for the Argentina nuclear industry Government has the goal to more than double nuclear power usage—and attendant uranium use– by 2025 to 1.25 million lbs.

A local uranium supply, such as those Blue Sky is developing, would have a significant cost advantage over imports. Argentina’s need for security of supply could provide a “guaranteed” first customer for a domestic supplier. Blue Sky has exclusive rights to more than 420k hectares. (5200 sq.km.)

On March 20, 2017, Blue Sky announced that it expects to release results soon from its completed drilling program at its Amarillo Grande project in Rio Negro province; 94 holes drilled totaling 1276 metres. BSK’s crews are now moving onto the Anit area, approximately 50 kilometres to the northwest along the 140-kilometre long uranium trend that comprises the Amarillo Grande Project.

“We are excited to be active in the Province of Rio Negro where a thriving nuclear converter industry exists since the 1970s, but no uranium production,” stated Nikolaos Cacos, President and CEO. “Blue Sky’s 420,000 hectares of property situated in two distinct regions has the potential to become the first domestic source of uranium for Argentina. The current program at Amarillo Grande is testing the mineralization occurrence at surface, and, depending on results, would be expanded to test at depth.”

The Amarillo Grande Project could well be the first domestic suppliers of uranium in Argentina, which is growing rapidly. The Company’s further goals include adding areas of exceptional uranium potential. As well, BSK plans to be self-financing as soon as practicable.

BSK has several competitive advantages and barriers to entry, these being primarily:

– No domestic uranium supply in Argentina means there is an opportunity window for local, low-cost, near-term producers to supply the local nuclear market

– Blue Sky controls new uranium district: Amarillo Grande Project in Rio Negro province

– Near-surface mineralization

– Expansion potential along trend and at depth

– Mining and Nuclear permissive jurisdiction

– Exclusive rights to over 280,000 in Rio Negro

– 140 km long trend of uranium mineralization

Blue Sky’s actions are all geared toward producing an NI 43-101, again as soon as practicable. Pending drilling results should establish more insight into the reserve potential of these unique properties.

Ever since the Fukashima melt down, uranium has been merely a faint blip on investors’ radar screens. At the very least the recent price rise from $18 a pound to $24 shows a surprising resilience.

According to the World Nuclear Association, there are globally, some 440 nuclear power reactors operating in 31 countries plus Taiwan, with a combined capacity of over 385 GWe. In 2014, these provided 2411 billion kWh, over 11% of the world’s electricity.

Over 60 power reactors are currently being constructed in 13 countries plus Taiwan (see Table below), notably China, South Korea, UAE and Russia. In all, over 160 power reactors with a total net capacity of some 182,000 MWe are planned and over 300 more are proposed.

There are obviously potential export opportunities for BSK from Argentina. Its ‘First Miner’ position in a country with an aggressive facilities and consumption growth and no domestic supply of uranium is extremely unique. Limited if any competition and strong government support makes the growth of BSK quite compelling.

Investors have seen shares of juniors in areas such as Canada’s Athabasca region rise and mining investor veterans such as Lundin, Rule, Casey and Friedland have made sizeable uranium bets. As mentioned above, early price moves are agnostic as to company size or geographic location or even level of development.

BSK shares have moved from C$0.22 cents on November 16, 2016 to C$0.49 cents on December 19th, 2016 and has settled in the C$0.39-C$0.40 cent range.

In conclusion, there are several uranium stocks investors could buy. And you’d likely make money: Eventually.

Blue Sky is that type of stock that brings all the standard tenets to a junior miner, but finds itself in the unique position of being in the middle of a country—Argentina—that has an aggressive nuclear power growth plan but imports all its fuel.

Soon, BSK could find itself—and is planning to be—the primary and potentially exclusive source of uranium for Argentina and possibly other South American countries.

Legal Disclaimer/Disclosure: This document is not and should not be construed as an offer to sell or the solicitation of an offer to purchase or subscribe for any investment. No information in this Report should be construed as individualized investment advice. A licensed financial advisor should be consulted prior to making any investment decision. We make no guarantee, representation or warranty and accept no responsibility or liability as to its accuracy or completeness. Baystreet.ca assumes no warranty, liability or guarantee for the current relevance, correctness or completeness of any information provided within this Report and will not be held liable for the consequence of reliance upon any opinion or statement contained herein or any omission. Furthermore, we assume no liability for any direct or indirect loss or damage or, in particular, for lost profit, which you may incur as a result of the use and existence of the information, provided within this Report.

Contact:

Aaron Bodnar aaron@baystreet.ca

SOURCE: Baystreet Media Corp.

ReleaseID: 457804

NEW YORK, NY / ACCESSWIRE / March 21, 2017 / Traders News Source, a leading independent equity research and corporate access firm focused on small and micro-cap public companies, is issuing a comprehensive report with no obligation on Potnetwork Holding, Inc. (OTC PINK: POTN). Potnetwork is a publicly traded company that has two wholly owned subsidiaries, First Capital Venture Co., the makers of Diamond CBD, and Sunrise Auto Mall Inc. Diamond CBD is focused on the advanced research and development of hemp extracts and distributing its ever growing and popular line of products in the global marketplace. POTN, acting as the holding company for the present subsidiaries, is planning to continue to expand from within, as well as through future acquisitions.

The company recently announced to move its domiciled state of Wyoming to Colorado; the filing was approved and is effective immediately. The announcement came just after POTN’s acquisition of Diamond CBD. Management believes that Colorado provides them with a relatively conducive environment, including beneficial landscape, for conducting its business in a cost-effective manner.

Our full comprehensive review of Potnetwork is available here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/potn/

Unique Differentiating Factors for Diamond CBD

Diamond CBD’s products are USA-made and produced with Cannabidiol (CBD) derived from the industrial hemp plant. According to the National Institute of Drug Abuse (NIDA), CBD oil may be effective in controlling epileptic seizures, reducing pain and inflammation, and may also be an effective treatment for mental health disorders, such as addiction and various forms of psychosis.

The Company formulates top quality hemp extracts that contain a broad profile of cannabinoids and other natural hemp derived molecules, resulting in a robust selection of Industrial Hemp Derived Diamond CBD oils considered among the most powerful natural CBD E-Liquids on the market.

An outlook for POTN over the near to medium term, as well as key stock influences, are discussed here: READ MORE.

Copy and paste to your browser may be required to view the report: http://tradersnewssource.com/potn/

DISCLOSURE

Traders News Source LLC (TNS) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering small and micro-cap equity markets. TNS has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles, and reports covering equities listed on NYSE, NASDAQ, and OTC exchanges. The other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles, and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

TNS has not been compensated, directly or indirectly, for producing or publishing this document.

PRESS RELEASE PROCEDURES

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a chartered financial analyst, for further information on analyst credentials, please email editor@tradersnewssource.com. Vikas Agrawal, a CFA® charter holder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written, and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author per the procedures outlined by TNS. TNS is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents, or reports. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

TNS, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake, or shortcoming. No liability is accepted whatsoever for any direct, indirect, or consequential loss arising from the use of this document. TNS, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise, arising from any reliance placed on the information in this document. Additionally, TNS, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness, or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither TNS, nor any party affiliated with us, is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.tradersnewssource.com.

For any questions, inquiries, or comments, reach out to us directly. If you’re a company we are covering and wish to no longer be featured on our coverage list, contact us via email between 09:30 EST to 16:00 EST from Monday through Friday at: editor@tradersnewssource.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

CONTACT:

editor@tradersnewssource.com

SOURCE: Traders News Source

ReleaseID: 457776

The University’s Innovation Institute Will Collaborate with Helomics to Co-Develop New Intellectual Property and to Commercialize Existing University Technologies

PITTSBURGH, PA / ACCESSWIRE / March 21, 2017 / Helomics® Corporation (Helomics), a privately-held healthcare company providing personalized medicine solutions for clients in the pharmaceutical, diagnostic, and biotech industries, and The University of Pittsburgh – Of the Commonwealth System of Higher Education (Pitt), today announced the completion of a Master Research and Development Collaboration Agreement. Under the terms of this five-year agreement, Helomics will collaborate with the University’s Innovation Institute to co-develop new intellectual property and to commercialize existing University intellectual property and technologies.

Marc S. Malandro, PhD, CLP, RTTP, Founding Director of the Innovation Institute, and Vice Chancellor for Technology Management and Commercialization at the University of Pittsburgh, commented, “We look forward to collaborating with one of Western Pennsylvania’s leading biotechnology companies to provide real-world validation of Pitt technologies in the areas of diagnostics and personalized medicine. This new alliance reflects the University’s strategic priority to create mutually beneficial partnerships for commercializing our discoveries and technologies.”

“We are very excited about this strategic collaboration with the University of Pittsburgh and the Innovation Institute,” stated Gerald J. Vardzel Jr., President and CEO of Helomics. “The University of Pittsburgh is one of the leading academic and biomedical research universities in the world. This collaboration with the University will be instrumental to Helomics in achieving our mission of improving the standard of care for patients by bringing unique diagnostic tests and technologies to the market.”

About Helomics® Corporation

Helomics® is an integrated clinical contract research organization whose mission is to improve patient care by partnering with pharmaceutical, diagnostic, and academic organizations to bring innovative clinical products and technologies to the marketplace. Helomics offers advanced clinical laboratory diagnostic tests, as well as scientific and non-scientific product enhancement services to provide a customized solution to our client’s specific product development needs.

Helomics® is headquartered in Pittsburgh, Pennsylvania where the company maintains state-of-the-art, CLIA-certified, clinical and research laboratories. For more information, please visit: www.helomics.com.

About The University of Pittsburgh Innovation Institute

Established in 2013, The University of Pittsburgh Innovation Institute is the University’s hub for innovation and entrepreneurship. The Innovation Institute provides a comprehensive suite of services for Pitt Innovators, from protecting intellectual property to the commercialization of new discoveries through licensing and/or new enterprise development. The Institute also provides a wealth of educational programming, mentoring and networking for Pitt faculty, students and partners. The Innovation Institute is strengthening the culture of innovation and entrepreneurship at Pitt and is eager to facilitate and support entrepreneurial initiatives across the university. It is also invites alumni, entrepreneurs and industry partners to collaborate with our faculty and students to help achieve societal impact through commercialization. Through the affiliated Institute for Entrepreneurial Excellence, the Innovation Institute also assists entrepreneurs throughout Western Pennsylvania in starting, growing, or transitioning their businesses. For more information please visit: www.innovation.pitt.edu.

Safe Harbor Statement

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release may contain forward-looking information within the meaning of Section 27A Of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words “believes,” “expects,” “anticipates,” or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company to differ materially from those expressed or implied by such forward-looking statements.

For more information regarding Helomics Corporation, please contact:

Michelle Murgia, Marketing Communications and Design
Helomics Corporation
mmurgia@helomics.com
412-432-1363

For more information regarding The University of Pittsburgh Innovation Institute, please contact:

Michael Yeomans, Marketing and Special Events Manager
The University of Pittsburgh Innovation Institute
myeomans@innovation.pitt.edu
(412) 624-4474

SOURCE: Helomics® Corporation and The University of Pittsburgh Innovation Institute

ReleaseID: 457759

LOS ANGELES, CA / ACCESSWIRE / March 21, 2017 / Oxis International Inc. (OTCQB: OXIS) (Euronext Paris OXI.PA) announced today that Dr. Daniel Vallera, a member of the Scientific Advisory Board of its wholly owned subsidiary, Oxis Biotech Inc., has been invited to speak at the 15th National Conference of Tumor Immunotherapy on June 22, 2017, in Hefei, China.

Dr. Vallera, Director of the section on Molecular Cancer Therapeutics at the University of Minnesota Masonic Cancer Center, said he will discuss two immunotherapy cancer treatments that he helped develop — Trispecific Killer Engager (TriKE) and Bispecific Killer Engager (BiKE). Both platforms have been licensed by Oxis.

The treatments empower the body’s immune system to identify and selectively kill cancer cells, while leaving healthy cells alone.

Dr. Vallera was instrumental in the development of Oxis’ promising cancer therapy, OXS-1550, which is currently in an FDA Phase 1/Phase 2 clinical trial in Minnesota.

The National Conference of Tumor Immunotherapy focuses on research, technology, clinical practice and government policy related to tumor immunology and immunotherapy. About 500 people are expected to attend.

Anthony Cataldo, Chairman and Chief Executive Officer of Oxis, said Dr. Vallera’s invitation is an indication that his work is widely recognized by his peers.

“We have received many requests for more information about the BiKE and TriKE platforms we have licensed from the University Of Minnesota,” Mr. Cataldo said. “The biotech community realizes the potential for this technology and how it addresses the future of ‘Targeted Immunotherapy.'”

Dr. Vallera has spent 35 years with the University of Minnesota’s cancer center, where he oversees a laboratory specializing in the development of biological recombinant drugs focusing on bispecific antibody therapies that directly deliver toxic signals to cancer cells.

About Oxis Biotech, Inc.:

Oxis Biotech is an immuno-oncology focused company developing innovative drugs focused on the treatment of cancer and other unmet medical needs. OXIS’ lead drug candidate, OXS-1550 (DT2219ARL) is a novel bispecific scFv recombinant fusion protein-drug conjugate composed of the variable regions of the heavy and light chains of anti-CD19 and anti-CD22 antibodies and a modified form of diphtheria toxin as its cytotoxic drug payload. OXS-1550 targets cancer cells expressing the CD19 receptor or CD22 receptor or both receptors. When OXS-2175 binds to cancer cells, the cancer cells internalize the drug and are killed due to the action of drug’s cytotoxic payload. OXS-1550 has demonstrated success in early human clinical trials in patients with relapsed/refractory B-cell lymphoma or leukemia. OXS-4235 is a small molecule therapeutic candidate targeting the treatment of multiple myeloma and associated osteolytic lesions. In in vitro and in vivo models of multiple myeloma and osteoporosis, OXS-4235 demonstrated the ability to kill multiple myeloma cells, and decrease osteolytic lesions in bone. OXIS’ lead drug candidate, OXS-2175, is a small molecule therapeutic candidate targeting the treatment of triple-negative breast cancer (TNBC). In in vitro and in vivo models of TNBC, OXS-2175 demonstrated the ability to inhibit metastasis.

Forward-Looking Statements:

Except for historical information contained herein, the statements in this release are forward-looking and made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements are inherently unreliable and actual results may differ materially. Examples of forward-looking statements in this news release include statements regarding the payment of dividends, marketing and distribution plans, development activities and anticipated operating results. Factors which could cause actual results to differ materially from these forward-looking statements include such factors as the Company’s ability to accomplish its business initiatives, significant fluctuations in marketing expenses and ability to achieve and expand significant levels of revenues, or recognize net income, from the sale of its products and services, as well as the introduction of competing products, or management’s ability to attract and maintain qualified personnel necessary for the development and commercialization of its planned products, and other information that may be detailed from time to time in the Company’s filings with the United States Securities and Exchange Commission. The Company undertakes no obligation to publicly update or revise any forward-looking statements, whether as a result of new information, future events or otherwise.

Company website: www.oxis.com

Contact:

Stuart Pfeifer
Sitrick & Co.
(310) 788-2850 or
spfeifer@sitrick.com

SOURCE: Oxis International Inc.

ReleaseID: 457790

VANCOUVER, BC / ACCESSWIRE / March 21, 2017 / Maritime Resources Corp. (TSXV: MAE) (“Maritime” or “the Company”) is very pleased to announce that it has concluded an option agreement to earn a 100% interest in a property covering a number of high grade gold veins close to the Company’s Hammerdown Gold Deposit in Newfoundland, Canada.

The 52-square kilometre Whisker Valley property (“Whisker”) consists of claim units owned by a Newfoundland prospecting partnership. Optioning these high grade, early discovery stage gold prospects is undertaken as a strategic move for Maritime. The property is located only 10 km from the re-developing Hammerdown – Green Bay Gold Project, with existing logging road connecting the two properties. New discoveries of significance at Whisker could allow for the expansion of the current Hammerdown resource and a common operating base for both projects. At present Hammerdown development plans envision trucking high-grade gold ore to the Nugget Pond gold mill, a distance of 140 km.

In Spring 2016, Bernard Kahlert P. Eng, VP of Exploration for Maritime, visited the property and examined several of the gold prospects. Specifically, the Gold Pit, White Face, Ben’s Showing and Jackson Vein in the south-central portion of the property were examined. All veins where narrow and consisted of quartz-carbonite matrix with pyrite and variable copper mineralization. Occasional flecks of gold were visible. Alteration consisted variably of silica, sericite, chlorite, hematite and bleaching. The veins were of limited length of 20 to 50 metres, this was mainly due to limited exposure in the extensive moss-overburden covered area. Almost all exposures were uncovered by hand and machine trenching by the prospectors.

Kahlert collected 11 vein grab samples, nine of which assayed very high gold, from 13.3 to 30.5 g/t Au with silver values ranging from 11.8 to 37.2 g/t Ag. Copper values were moderately anomalous, with one sample exceeding 1.0% Cu. The table below shows Au – Ag – Cu values for the 11 samples.

Whisker Valley – Table of Assays

SAMPLE NUMBER
GOLD
g/t
SILVER
ppm
COPPER
ppm
640901
24.6
11.8
1714
640902
2.154
1.8
810
640903
19.6
13.3
221
640904
30.5
20.6
7345
640905
24.6
27.2
7058
640906
17.3
33.0
5820
640907
0.045
<0.3
274
640908
19.4
31.9
4280
640909
25.8
37.2
4295
640910
27.2
26.4
4068
640911
13.3
16.6
>10000

Geologically, the property is situated within the Dunnage Zone of central Newfoundland which forms an extension of the continental Appalachian belt. About 75% of the property is underlain by mid-Paleozoic rhyolites, basalts, tuffaceous sequences and minor sediments which have all been intruded by local felsic bodies. The Northwest 25% of the property covers part of the extensive Bourlamaque Plutonic suite of granite-granodiorite composition.

The highly experienced local prospectors discovered high grade gold bearing veins on the Whisker property over the last 7-8 years. After locating and assaying several quartz veins with strong gold values in road cuts, they launched extensive prospecting programs on the property, with hand tools and later excavators, they continued to make more gold discoveries, which now total over ten prospects. Most of these return prospecting samples assaying over 2 gm / t Au, with over 12 exceeding 10 gm / t Au and several spectacular assays exceeding 100 g / t Au. Visible gold is noted in several locations.

Although the veins seem of limited width, they are very high grade, similar to the Company’s Hammerdown veins a short distance away. The abundance of these high-grade veins in a restricted area indicates a fertile gold system is active here.

Although no detailed structural work has been undertaken, an examination of local land forms shows there is a strong series of North-easterly trending structures crossing the property, spaced about 1 kilometre apart. These structures are parallel to the Hammerdown Gold deformation zone, all of which follow the major Green Bay Fault.

Doug Fulcher, President and CEO of Maritime commented:

“We are pleased to have entered into this agreement to acquire a 100% interest in an early stage high grade gold project in the Hammerdown area. The Whisker project sits within 10 km by road from the Hammerdown project and has demonstrated some of the same high grade gold that we have encountered at Hammerdown and Orion. It will be our intention to continue exploration at the Whisker Property while the development of Hammerdown is underway.

Terms of the Agreement

Under the terms of the agreement Maritime will earn 100% interest in the Whisker property over a 5-year period by spending $1.65-million in exploration ($100,000 in year one), make cash payments totaling $300,000 and issue 1.5 million shares of Maritime in accordance with the following schedule:

Upon signing pay $25,000 and 100,000 shares;

Year one anniversary — $20,000 and 150,000 shares and $100,000 work commitment;

Year two anniversary — $30,000 and 200,000 shares and $250,000 work commitment;

Year three anniversary — $50,000 and 250,000 shares and $300,000 work commitment;

Year four anniversary — $75,000 and 300,000 shares and $500,000 work commitment;

Year five anniversary — $100,000 and 500,000 shares and $500,000 work commitment.

2.5 % NSR of which 1% can be purchased up until the end of the second anniversary of commercial production for $1,000,000

ABOUT MARITIME RESOURCES CORP:

Maritime Resources holds 100% of the Green Bay Property, located near Springdale, Newfoundland and Labrador. The property hosts the past producing Hammerdown gold mine and the Orion gold deposit separated by a 1.5 km distance, as well as the Lochinvar base metals/precious metals deposit. Maritime announced a Prefeasibility Study (March 2nd, 2017) that evaluated the Measured & Indicated NI43-101 mineral resource estimate for the past producing Hammerdown gold deposit. The study was completed by WSP Canada Inc. (“WSP”), an independent third party engineering firm, with the mandate to evaluate the potential of bringing the past producing gold mine back into commercial production.

Pre – Feasibility highlights

Project Pre-tax net present value (‘NPV8%’) of $71.2 million with an IRR of 46.8% per cent.

Project after-tax net present value (‘NPV8%’) of $44.2 million with an internal rate of return (‘IRR’) of 34.8%

Net pre-tax cash flow of $104 million, undiscounted. Net after-tax cash flow of $69 million, undiscounted.

Mine life for the current plan at Hammerdown is five years, producing approximately 174,000 ounces at an average of approximately 35,000 ounces per year. Basic assumptions used for the compilation of the PFS:

Gold Price of US$ 1,250 per ounce

Exchange Rate of 0.8 US$: 1 CA$ (or 1 US$: 1.25 CA$)

Project discount rate of 8%

Mill recovery of 97% based on the historic treatment of the ore at the nearby Nugget Pond Gold Mill from 2000 to 2004.

(All currency is expressed in Canadian dollars ($CA) unless otherwise noted.)

The Hammerdown gold deposit was successfully mined by Richmont Mines between 2000 and 2004 while gold prices averaged $325/oz. During its operation, a total of 291,400 tonnes of ore were mined and milled, at an average grade of 15.83 g/t Au, recovering a total of 143,000 ounces of gold at an 8 g/t cut-off. All of the ore was processed at the Nugget Pond mill, now owned and operated by Rambler Metals and Mining Canada Limited, with an average gold recovery of 97.1%. Mining terminated in 2004 due to low gold prices with extensive gold mineralization remaining, although uneconomic at that time.

The Orion gold deposit consists of two main vein systems, both of which are open along strike, and down plunge to the northeast.

Bernard H. Kahlert, P.Eng. is the Qualified Person as defined by National Instrument 43-101 and has reviewed and approved the technical disclosure contained in this release.

On behalf of the Board of Directors

Doug Fulcher
President, CEO

Website: www.maritimeresourcescorp.com

For further information, please call:

Cathy DiVito, Investor Relations
Telephone: (604) 336-7322
info@maritimegold.com

Neither TSX Venture Exchange nor its Regulation Service Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

Caution Regarding Forward Looking Statements:

Certain information included in this press release, including information relating to future financial or operating performance and other statements that express the expectations of management or estimates of future performance constitute “forward-looking statements”. Such forward-looking statements include, without limitation, statements regarding copper, gold and silver forecasts, the financial strength of the Company, estimates regarding timing of future development and production and statements concerning possible expansion opportunities for the Company. Where the Company expresses or implies an expectation or belief as to future events or results, such expectation or belief are based on assumptions made in good faith and believed to have a reasonable basis. Such assumptions include, without limitation, the price of and anticipated costs of recovery of, copper concentrate, gold and silver, the presence of and continuity of such minerals at modeled grades and values, the capacities of various machinery and equipment, the availability of personnel, machinery and equipment at estimated prices, mineral recovery rates, and others. However, forward-looking statements are subject to risks, uncertainties and other factors, which could cause actual results to differ materially from future results expressed, projected or implied by such forward-looking statements. Such risks include, but are not limited to, interpretation and implications of drilling and geophysical results; estimates regarding timing of future capital expenditures and costs towards profitable commercial operations. Other factors that could cause actual results, developments or events to differ materially from those anticipated include, among others, increases/decreases in production; volatility in metals prices and demand; currency fluctuations; cash operating margins; cash operating cost per pound sold; costs per ton of ore; variances in ore grade or recovery rates from those assumed in mining plans; reserves and/or resources; the ability to successfully integrate acquired assets; operational risks inherent in mining or development activities and legislative factors relating to prices, taxes, royalties, land use, title and permits, importing and exporting of minerals and environmental protection. Accordingly, undue reliance should not be placed on forward-looking statements and the forward-looking statements contained in this press release are expressly qualified in their entirety by this cautionary statement. The forward-looking statements contained herein are made as at the date hereof and the Company does not undertake any obligation to update publicly or revise any such forward-looking statements or any forward-looking statements contained in any other documents whether as a result of new information, future events or otherwise, except as required under applicable security law.

SOURCE: Maritime Resources Corp.

ReleaseID: 457826